Market Cap
¥2.491 Trillion
JPY as of July 1, 2025
US$17.37 Billion
| Company | Market Cap (USD) |
|---|---|
Lilly
|
$699.59 B |
Johnson & Johnson
|
$374.29 B |
AbbVie
|
$336.94 B |
Roche
|
$260.54 B |
Novartis
|
$243.50 B |
| Company | Market Cap (USD) |
|---|---|
Lilly
|
$699.59 B |
Johnson & Johnson
|
$374.29 B |
AbbVie
|
$336.94 B |
Novo Nordisk
|
$309.91 B |
UnitedHealth Group
|
$279.90 B |
Top 1-year algo backtest: +327.04%
$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Japan
languages
Healthcare
languages
Drug Manufacturers—General
Japan Healthcare
Japan Drug Manufacturers—General
Astellas Pharma, Inc. has the following listings and related stock indices.
Stock: JPX: 4503
Stock: FSX: YPH
Stock: FSX: YPHA
Stock: OTC: ALPMF
Stock: OTC: ALPMY
The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.